Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.629ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21568.6Japan
FL.30.1ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21581.3Japan
CQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.2.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
CQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
CR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.5.2.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
B.1.595NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BQ.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
XBB.2.3.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
AF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
B.1.350NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
B.1.194NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BL.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21588.8US
B.1.501NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.505NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.498NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.500NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.506NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.499.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.508NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.504NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.507NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
XDNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.499NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.503NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
B.1.502NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21599.5US
BA.5.2.25NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-21639.2US
HC.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-21664.7Japan
B.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-21683South Korea
B.1.1.487NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21719.1US
KH.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21719.1US
GS.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21719.1US
BA.5.1.19NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21721.9US
BN.1.4.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-21734.9Japan
A.23.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
B.1.218NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
B.1.632NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
B.1.247NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
B.1.442NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
B.1.164NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21742.5China
FQ.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
BQ.1.1.71NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
BQ.1.1.39NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
EV.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
GK.1.10.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21745Germany
BN.1.4.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-21779.1China
BN.1.4.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-21781.5Singapore
XBB.1.5.25SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-21781.5Singapore
CF.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-21781.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used